Brazil’s Anvisa approves extending the use of CoronaVac to children and adolescents aged 6 to 17 years
The emergency use authorization granted this Thursday (01/20) is valid only for the age group 6 to 17 years old.
The emergency use authorization granted this Thursday (01/20) is valid only for the age group 6 to 17 years old.